IMMUNO-COV™ – The Test for Antibodies that Block SARS-CoV-2 Infection Read More

March 18-22, 2019

Immuno-Oncology Summit Europe

Stephen J. Russell, M.D., Ph.D., Vyriad President and Chief Executive Officer
Presentation: “Vyriad’s Voyager-V1 Program: Pharmacological Enhancement of a Systemically Active, Single Cycle Oncolytic Virus”

Visit event site

Media Inquiries

For inquiries, please contact